Bionano Genomics Analyst Ratings
Scotiabank Maintains Bionano Genomics(BNGO.US) With Hold Rating, Maintains Target Price $1
Scotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)
Ladenburg Thalmann Downgrades Bionano Genomics(BNGO.US) to Hold Rating
Bionano Genomics Analyst Ratings
BTIG Downgrades Bionano Genomics(BNGO.US) to Hold Rating
Bionano Genomics Analyst Ratings
Scotiabank Downgrades Bionano Genomics(BNGO.US) to Hold Rating, Cuts Target Price to $1
BTIG Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $2
Buy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial Planning
Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO)
Bionano Genomics Analyst Ratings
Strong Performance and Strategic Initiatives Underpin Buy Rating for BioNano Genomics
BioNano Genomics (BNGO) Gets a Buy From Scotiabank
BioNano Genomics (BNGO) Gets a Hold From Maxim Group
Bionano Genomics Analyst Ratings
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk
Analysts Are Bullish on Top Healthcare Stocks: BioNano Genomics (BNGO), Legend Biotech (LEGN)
Maxim Group Remains a Hold on BioNano Genomics (BNGO)
BioNano Genomics (BNGO) Gets a Buy From BTIG